Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis.

IF 5.2 2区医学 Q1 ENDOCRINOLOGY & METABOLISM Current Diabetes Reports Pub Date : 2023-06-01 DOI:10.1007/s11892-023-01506-2

Jinguo Jiang, Tingjing Zhang, Yashu Liu, Qing Chang, Yuhong Zhao, Chuanji Guo, Yang Xia

{"title":"Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis.","authors":"Jinguo Jiang, Tingjing Zhang, Yashu Liu, Qing Chang, Yuhong Zhao, Chuanji Guo, Yang Xia","doi":"10.1007/s11892-023-01506-2","DOIUrl":null,"url":null,"abstract":"Purpose of review: To perform a systematic review and meta-analysis of the prevalence of diabetes in patients with hyperuricemia and gout.Recent findings: Previous studies have confirmed that hyperuricemia and gout are associated with an increased risk of diabetes. A previous meta-analysis indicated that the prevalence of diabetes in patients with gout is 16%. Thirty-eight studies (458,256 patients) were included in the meta-analysis. The combined prevalence of diabetes among patients with hyperuricemia and gout were 19.10% (95% confidence interval [CI]: 17.60-20.60; I2 = 99.40%) and 16.70% (95% CI: 15.10-18.30; I2 = 99.30%), respectively. Patients from North America showed a higher prevalence of diabetes (hyperuricemia: 20.70% [95% CI: 16.80-24.60], gout: 20.70% [95% CI: 16.80-24.60]) than those from other continents. Older patients with hyperuricemia and those using diuretics showed a higher prevalence of diabetes than younger patients and those who were not using diuretics. Studies with a small sample size, case-control design, and low quality score had a higher prevalence of diabetes than studies with a large sample size, other designs, and a high quality score. The prevalence of diabetes among patients with hyperuricemia and gout is high. Controlling plasma glucose and uric acid levels of patients with hyperuricemia and gout is critical for the prevention of diabetes.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 6","pages":"103-117"},"PeriodicalIF":5.2000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Diabetes Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11892-023-01506-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: To perform a systematic review and meta-analysis of the prevalence of diabetes in patients with hyperuricemia and gout.

Recent findings: Previous studies have confirmed that hyperuricemia and gout are associated with an increased risk of diabetes. A previous meta-analysis indicated that the prevalence of diabetes in patients with gout is 16%. Thirty-eight studies (458,256 patients) were included in the meta-analysis. The combined prevalence of diabetes among patients with hyperuricemia and gout were 19.10% (95% confidence interval [CI]: 17.60-20.60; I² = 99.40%) and 16.70% (95% CI: 15.10-18.30; I² = 99.30%), respectively. Patients from North America showed a higher prevalence of diabetes (hyperuricemia: 20.70% [95% CI: 16.80-24.60], gout: 20.70% [95% CI: 16.80-24.60]) than those from other continents. Older patients with hyperuricemia and those using diuretics showed a higher prevalence of diabetes than younger patients and those who were not using diuretics. Studies with a small sample size, case-control design, and low quality score had a higher prevalence of diabetes than studies with a large sample size, other designs, and a high quality score. The prevalence of diabetes among patients with hyperuricemia and gout is high. Controlling plasma glucose and uric acid levels of patients with hyperuricemia and gout is critical for the prevention of diabetes.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

糖尿病在高尿酸血症和痛风患者中的患病率:一项系统回顾和荟萃分析。

综述的目的:对高尿酸血症和痛风患者中糖尿病患病率进行系统回顾和荟萃分析。最近的发现:先前的研究已经证实，高尿酸血症和痛风与糖尿病风险增加有关。先前的荟萃分析表明，痛风患者中糖尿病的患病率为16%。38项研究(458,256例患者)纳入meta分析。合并高尿酸血症和痛风的患者中糖尿病的总患病率为19.10%(95%可信区间[CI]: 17.60-20.60;I2 = 99.40%)和16.70% (95% CI: 15.10-18.30;I2 = 99.30%)。北美患者的糖尿病患病率(高尿酸血症:20.70% [95% CI: 16.80-24.60]，痛风:20.70% [95% CI: 16.80-24.60])高于其他大洲的患者。老年高尿酸血症患者和使用利尿剂的患者糖尿病患病率高于年轻患者和未使用利尿剂的患者。小样本量、病例对照设计和低质量评分的研究比大样本量、其他设计和高质量评分的研究有更高的糖尿病患病率。糖尿病在高尿酸血症和痛风患者中的患病率很高。控制高尿酸血症和痛风患者的血糖和尿酸水平对预防糖尿病至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Diabetes Reports 医学 -

CiteScore

9.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of diabetes epidemiology, pathophysiology, and management. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators. We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.